COR-2003
/ Corsera Health
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 06, 2026
A Study to Evaluate COR-2003 as Monotherapy and Co-Administered With COR-1004 in Adult Volunteers
(clinicaltrials.gov)
- P1 | N=108 | Not yet recruiting | Sponsor: Corsera Health
Monotherapy • New P1 trial • Dyslipidemia
1 to 1
Of
1
Go to page
1